Evidence map›Paper›PMID 35645956›Full record

ArticleFrontiers in neurology2022

Can CHA

Elisa Bianconi, Giulia Del Freo, Emilia Salvadori, Carmen Barbato, Benedetta Formelli, Francesca Pescini, Giovanni Pracucci, Cristina Sarti, Francesca Cesari, Stefano Chiti and 8 more

Open access · goldAbstract read
PubMed Full text at PMC Publisher
In one paragraph

Article in Frontiers in neurology, 2022. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 1 paper.

0numbers the graph read from it
0cells of the map it votes in
1citing papers in PubMed
0.3field-weighted citation impact, top 41% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

1 citing paper in PubMed, 3 citations in OpenAlex.

  1. Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

18 authors at 5 institutions in 1 country.

Elisa BianconiDepartment of Statistics, Computer Science, Applications ≪ G. Parenti ≫, University of Florence, Florence, Italy.
Giulia Del FreoDepartment of Statistics, Computer Science, Applications ≪ G. Parenti ≫, University of Florence, Florence, Italy.
Emilia SalvadoriNEUROFARBA Department, Neuroscience Section, University of Florence, Florence, Italy.
Carmen BarbatoNEUROFARBA Department, Neuroscience Section, University of Florence, Florence, Italy.
Benedetta FormelliNEUROFARBA Department, Neuroscience Section, University of Florence, Florence, Italy.
Francesca PesciniStroke Unit, Careggi University Hospital, Florence, Italy.
Giovanni PracucciNEUROFARBA Department, Neuroscience Section, University of Florence, Florence, Italy.
Cristina SartiNEUROFARBA Department, Neuroscience Section, University of Florence, Florence, Italy.
Francesca CesariCentral Laboratory, Careggi University Hospital, Florence, Italy.
Stefano ChitiDepartment Health Professions, U.O. Research and Development, Careggi University Hospital, Florence, Italy.
Stefano DiciottiDepartment of Electrical, Electronic, and Information Engineering "Guglielmo Marconi", University of Bologna, Cesena, Italy.
Anna Maria GoriDepartment of Experimental and Clinical Medicine, University of Florence, Florence, Italy.
Chiara MarziInstitute of Applied Physics "Nello Carrara" (IFAC), National Research Council of Italy (CNR), Florence, Italy.
Enrico FainardiNeuroradiology Unit, Department of Experimental and Clinical Biomedical Sciences, Careggi University Hospital, University of Florence, Florence, Italy.
Betti GiustiDepartment of Experimental and Clinical Medicine, University of Florence, Florence, Italy.
Rossella MarcucciDepartment of Experimental and Clinical Medicine, University of Florence, Florence, Italy.
Bruno BertacciniDepartment of Statistics, Computer Science, Applications ≪ G. Parenti ≫, University of Florence, Florence, Italy.
Anna PoggesiNEUROFARBA Department, Neuroscience Section, University of Florence, Florence, Italy.
University of Florence · ITAzienda Ospedaliero-Universitaria Careggi · ITDon Carlo Gnocchi Foundation · ITMarconi University · ITNational Research Council · IT

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Anticoagulants reduce embolic risk in atrial fibrillation (AF), despite increasing hemorrhagic risk. In this context, validity of congestive heart failure, hypertension, age ≥ 75 years, diabetes, stroke, vascular disease, age 65-74 years and sex category (CHA

Indexed as

anticoagulationatrial fibrillationbrain MRIcerebral small vessel diseaseCHA2DS2-VASc scaleHAS-BLED scaleintracerebral hemorrhagestroke

Identifiers

PMID35645956
PMCPMC9135961
OpenAlexW4280601340

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.